R-isovaline: a subtype-specific agonist at GABAB-receptors?

  title={R-isovaline: a subtype-specific agonist at GABAB-receptors?},
  author={James E. Cooke and David A. Mathers and Ernest Puil},

Figures and Tables from this paper

GABAB modulation of dopamine release in the nucleus accumbens core
Baclofen‐mediated suppression of terminal DA release is due to GABAB activation on DA terminals to reduce the probability of DA release, suggesting a mechanistic overlap with D2 receptors.
Isovaline: A unique amino acid with antiepileptic drug properties
The latest published findings which demonstrate the efficacy of isovaline in an in vivo rat model of epilepsy are discussed, which is a clear need to develop new AEDs that may work via novel mechanisms to provide greater efficacy.
Variations of isovaline structure related to activity in the formalin foot assay in mice
Findings indicate that the conformational stability of isovaline or the ability to form a cyclobutane ring is necessary for activity in the formalin foot assay.
The Efficacy and Safety of the Novel Peripheral Analgesic Isovaline as an Adjuvant to Propofol for General Anesthesia and Conscious Sedation: A Proof-of-Principle Study in Mice
The novel analgesic, isovaline, coadministered with propofol, produced general anesthesia and conscious sedation in mice and provides proof of the principle of combining a peripheral analgesic with a centrally acting hypnotic to produce general anesthesia.
Antinociception by intrathecal delivery of the novel non‐opioid 1‐amino‐1‐cyclobutanecarboxylic acid
Whether intrathecal administration of 1‐amino‐1‐cyclobutanecarboxylic acid produces antinociceptive effects in murine models and to elucidate its site and receptor mechanism of action is determined.


Isovaline causes inhibition by increasing potassium conductance in thalamic neurons
μ-Opioid Peptides Inhibit Thalamic Neurons
The results suggest that the net action of opioids would depend on their source: exogenous (systemically administered) opiates inhibiting the entire thalamus and favoring the shift of cell firing from tonic to bursting mode; and endogenously released opioids acting on specific thalamic nuclei, their release depending on the origin of the presynaptic input.
CGP 35348: a centrally active blocker of GABAB receptors.
Two Metabotropic γ-Aminobutyric Acid Receptors Differentially Modulate Calcium Currents in Retinal Ganglion Cells
This study demonstrates that ganglion cells possess two types of metabotropic GABAB receptor: one sensitive to baclofen and another to cis-aminocrotonic acid (CACA), providing a wide range of neural integration at the final stage of retinal information processing.
Native GABAB receptors are heteromultimers with a family of auxiliary subunits
It is shown by functional proteomics that GABAB receptors in the brain are high-molecular-mass complexes of GABAB1, GABAB2 and members of a subfamily of the KCTD (potassium channel tetramerization domain-containing) proteins, established as auxiliary subunits of GABAb receptors that determine the pharmacology and kinetics of the receptor response.
Analgesic Properties of the Novel Amino Acid, Isovaline
Isovaline reduced responses in mouse pain models without producing acute toxicity, possibly by enhancing receptor modulation of nociceptive information.
The α9 Nicotinic Acetylcholine Receptor Shares Pharmacological Properties with Type A γ-Aminobutyric Acid, Glycine, and Type 3 Serotonin Receptors
The present results suggest that the α9 nAChR must conserve in its primary structure some residues responsible for ligand binding common to other Cys-loop receptors.
GABAB-receptor subtypes assemble into functional heteromeric complexes
A new GABAB receptor subtype is described, GABABR2, which does not bind available GABAB antagonists with measurable potency and exhibits a significant increase in agonist- and partial-agonist-binding potencies as compared with individual receptors.
Endogenous RGS proteins enhance acute desensitization of GABAB receptor-activated GIRK currents in HEK-293T cells
It is demonstrated that endogenous levels of RGS proteins effectively enhance GABAB receptor-dependent desensitization of GIRK currents, and heterologous desensITization was observed between GABAB receptors and MOR.